Pharmaceutical Manufacturing Unit (Betalactam and NonBetalactam)
PROJECT DESCRIPTION
Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.
Beta-lactam antibiotics, including penicillins and the non-penicillin classes, share a basic chemical structure that includes a three-carbon, one-nitrogen cyclic amine structure known as the beta-lactam ring.The side chain associated with the beta-lactam ring is a variable group attached to the core structure by a peptide bond; the side chain variability contributes to antibacterial activity.
Various industry reports suggest that the pharmaceutical sector in India has been growing consistently at the rate of 13-14 % every year.India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level.As a whole it is a good project for new entrepreneurs to invest.
Few Indian Major Players are as under
• AurobindoPharma Ltd.
• Arbro Pharmaceuticals Pvt. Ltd.
• Bafna Pharmaceuticals Ltd.
• Fermenta Biotech Ltd.
• Medreich Ltd.
• NitinLifesciences Ltd.
• Shreya Life Sciences Pvt. Ltd.
• Taj Pharmaceuticals Ltd.
| Plant capacity |
Plant & machinery |
Working capital |
Cost of Project |
T.C.I |
Return |
Break even |
| Betalactam Cephalexin Tablets 400 mg: 3,000,000 Nos./annum Betalactam Cephalexin Capsules 400 mg:3,000,000 Nos./annum Betalactam Cephalexin Syrup 50 ml:1,500,000 Nos./annum Betalactam Cephalexin Dry Syrup 30 ml:1,500,000 Nos./annum Betalactam Cephalexin S |
Rs 103 lakhs |
- |
145200000 |
Cost of Project: Rs 1452 lakhs |
33.00 |
45.00 |